Security
Oramed Pharmaceuticals Inc. Common Stock · ORMP
ORMPNASDAQCommon stockCurrentCIK 1176309Updated Nov 13, 2026
ORMP price & chart
Loading TradingView…
NASDAQ:ORMP on TradingView ↗About the company
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) is a clinical-stage pharmaceutical company and platform technology pioneer in oral delivery solutions for drugs currently delivered via injection. Oramed’s Protein Oral Delivery (POD™) technology is designed to protect drug integrity and increase absorption. Oramed is building a diversified active investment portfolio while advancing its refined oral insulin program.
In the news
Oramed Reports Fiscal Third Quarter 2025 Financial Results News provided by Oramed Pharmaceuticals Inc. Nov 17, 2025, 08:56 ET Share this article Share to X Share this article Share to X Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to $220.5 Milli ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2021 | Q2 2021 | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 80,492,000Source | 61,657,000Source | 230,864,000Source | 155,278,000Source | 220,551,000Source | 161,642,000Source | 182,450,000Source | 40,971,000Source | 230,864,000Source | 155,278,000Source | 220,551,000Source | 161,642,000Source |
| Property, Plant and Equipment, NetUSD | 389,000Source | 415,000Source | 586,000Source | 698,000Source | 873,000Source | 815,000Source | 385,000Source | 409,000Source | 586,000Source | 698,000Source | 873,000Source | 815,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 57,414,000Source | 33,805,000Source | 45,947,000Source | — | 9,055,000Source | — | 31,880,000Source | 14,931,000Source | 45,947,000Source | — | 9,055,000Source | — |
| Assets, CurrentUSD | 72,233,000Source | 57,472,000Source | 133,271,000Source | 143,221,000Source | 162,584,000Source | 157,109,000Source | 152,332,000Source | 36,024,000Source | 133,271,000Source | 143,221,000Source | 162,584,000Source | 157,109,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,592,000Source | 683,000Source | 2,741,000Source | 1,291,000Source | 537,000Source | — | — | 1,676,000Source | 2,741,000Source | 1,291,000Source | 537,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 560,000Source | 608,000Source | 750,000Source | 414,000Source | 694,000Source | 987,000Source | 504,000Source | 640,000Source | 750,000Source | 414,000Source | 694,000Source | 987,000Source |
| Other Assets, NoncurrentUSD | — | — | 44,000Source | 32,000Source | — | — | — | — | 44,000Source | 32,000Source | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 366,000Source | 339,000Source | 472,000Source | 480,000Source | 485,000Source | 476,000Source | 458,000Source | 286,000Source | 472,000Source | 480,000Source | 485,000Source | 476,000Source |
| Additional Paid in CapitalUSD | 175,751,000Source | 151,895,000Source | — | — | — | 314,417,000Source | 292,439,000Source | 126,110,000Source | — | — | — | 314,417,000Source |
| Retained Earnings (Accumulated Deficit)USD | -107,999,000Source | -102,792,000Source | -123,436,000Source | -176,616,000Source | -157,556,000Source | -163,081,000Source | -122,742,000Source | -98,184,000Source | -123,436,000Source | -176,616,000Source | -157,556,000Source | -163,081,000Source |
| Stockholders' Equity Attributable to ParentUSD | 68,118,000Source | 49,442,000Source | — | 146,265,000Source | 163,821,000Source | 151,812,000Source | 170,155,000Source | 28,212,000Source | 199,744,000Source | 146,265,000Source | 163,821,000Source | 151,812,000Source |
| Additional Paid in Capital, Common StockUSD | — | — | 322,708,000Source | 322,401,000Source | 320,892,000Source | — | — | — | 322,708,000Source | 322,401,000Source | 320,892,000Source | — |
| Liabilities and EquityUSD | 80,492,000Source | 61,657,000Source | 230,864,000Source | 155,278,000Source | 220,551,000Source | 161,642,000Source | 182,450,000Source | 40,971,000Source | 230,864,000Source | 155,278,000Source | 220,551,000Source | 161,642,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 5,750,000Source | 5,932,000Source | 19,086,000Source | 5,685,000Source | 53,214,000Source | 5,746,000Source | 7,660,000Source | 5,742,000Source | 19,086,000Source | 5,685,000Source | 53,214,000Source | 5,746,000Source |
| Operating Lease, Liability, CurrentUSD | 129,000Source | 139,000Source | 285,000Source | 216,000Source | 267,000Source | 247,000Source | 130,000Source | 138,000Source | 285,000Source | 216,000Source | 267,000Source | 247,000Source |
| Accounts Payable, CurrentUSD | — | — | 443,000Source | 789,000Source | — | — | — | — | 443,000Source | 789,000Source | — | — |
| Operating Lease, Liability, NoncurrentUSD | 431,000Source | 469,000Source | 540,000Source | 156,000Source | 342,000Source | 647,000Source | 374,000Source | 502,000Source | 540,000Source | 156,000Source | 342,000Source | 647,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | 7,911,000Source | — | — | — | — | — | 7,911,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 160,000Source | 177,000Source | — | 60,000Source | — | — | — | 212,000Source | — | 60,000Source | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 1,077,000Source | — | — | -918,000Source | -928,000Source | -656,000Source | 536,000Source | — | — | -918,000Source | -928,000Source | -656,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | 1,084,000Source | 740,000Source | — | — | — | — | 1,084,000Source | 740,000Source | — | — |
| Deferred Revenue, CurrentUSD | 2,703,000Source | 2,703,000Source | — | — | — | — | 2,000,000Source | 2,703,000Source | — | — | — | 2,000,000Source |
| Deferred Revenue, NoncurrentUSD | 4,925,000Source | 5,606,000Source | — | — | 4,000,000Source | 4,000,000Source | 3,570,000Source | 6,273,000Source | — | — | 4,000,000Source | 4,000,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 7,911,000Source | — | — | — |
| Dividends Payable, CurrentUSD | — | — | 10,595,000Source | — | — | — | — | — | 10,595,000Source | — | — | — |
| Dividends PayableUSD | — | — | 275,000Source | — | — | — | — | — | 275,000Source | — | — | — |
| Long-term DebtUSD | — | — | — | — | — | — | 11,704,000Source | — | — | — | — | 25,000Source |
| Short-term InvestmentsUSD | — | 3,001,000Source | — | — | 57,713,000Source | — | — | 3,016,000Source | — | — | 57,713,000Source | — |
cash flow · annual statements
| Line item | Q4 2021 | Q2 2026 | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -8,098,000Source | 64,016,000Source | -19,060,000Source | 5,088,000Source | -37,764,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | 5,992,000Source | 4,053,000Source | 4,212,000Source | 11,509,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | 7,911,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,903,000Source | -9,145,000Source | -8,412,000Source | -10,295,000Source | -27,918,000Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -99,048,000Source | 5,443,000Source | 105,817,000Source | -73,038,000Source | 30,211,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 9,000Source | 18,000Source | 254,000Source | 496,000Source |
| Cash flows from financing activities: | |||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | 1,519,000Source | — | — | — | — | — | — | 2,000Source | — | 783,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | 4,741,000Source | 2,484,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 60,563,000Source | -4,741,000Source | -52,036,000Source | 51,978,000Source | 10,779,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -45,365,000Source | -8,473,000Source | 45,365,000Source | -31,409,000Source | 13,008,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 45,947,000Source | 54,420,000Source | 9,055,000Source | 40,464,000Source | 27,456,000Source | 45,947,000Source | 54,420,000Source | 9,055,000Source | 40,464,000Source |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 2,316,000Source | 574,000Source | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | — | 1,844,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | — | -30,000Source | -4,000Source | -54,000Source | — |
| Additional Financial Items | |||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | 5,152,000Source | 4,053,000Source | — | — |
| DepreciationUSD | — | — | — | — | — | — | 12,000Source | 121,000Source | 193,000Source | 196,000Source | 58,000Source |
| Dividends Payable, CurrentUSD | — | — | 10,595,000Source | — | — | — | — | 10,595,000Source | — | — | — |
| Dividends PayableUSD | — | — | 275,000Source | — | — | — | — | 275,000Source | — | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | 1,637,000Source | -7,784,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | 383,000Source | -252,000Source | 174,000Source | 2,172,000Source | 1,550,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | — | — | 13,000Source |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | 1,739,000Source | 8,720,000Source | 6,457,000Source | 8,425,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | 100,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | 11,308,000Source | 3,183,000Source | — | 100,000Source |
| InterestExpenseNonoperatingUSD | — | — | — | — | — | — | — | — | 853,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | — | — | — | — | -8,098,000Source | 64,050,000Source | -19,103,000Source | 5,525,000Source | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -208,000Source | -34,000Source | 43,000Source | -437,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | -7,890,000Source | 63,242,000Source | — | — | -36,561,000Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | 89,454,000Source | -2,286,000Source | 22,894,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | -606,000Source | 4,359Source | — | — |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | — | 1,307,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 10,617,000Source | — | — | 2,428,000Source | 10,617,000Source |
| Marketable Securities, Unrealized Gain (Loss) | — | — | — | — | — | — | —Source | — | — | — | — |
| Noncash Merger Related Costs | — | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses | — | — | — | — | — | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2022 | Q1 2021 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | 681,000Source | 665,000Source | 674,000Source | 674,000Source | 2,000,000Source | — | 1,340,000Source | 2,703,000Source |
| Cost of Goods and Services Sold | — | — | — | — | — | —Source | — | — | — |
| Operating Income (Loss)USD | — | -6,118,000Source | -4,868,000Source | -8,060,000Source | -5,827,000Source | -15,088,000Source | -12,781,000Source | -15,769,000Source | -40,598,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 260,000Source | — | 257,000Source | -606,000Source | 4,359Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -5,625,000Source | -4,608,000Source | — | — | 75,324,000Source | -15,920,000Source | 5,088,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | 11,308,000Source | 3,183,000Source | — | 100,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | -418,000Source | — | -208,000Source | — | -34,000Source | 43,000Source | -437,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | -5,207,000Source | -4,608,000Source | -8,098,000Source | -5,570,000Source | 64,050,000Source | -19,103,000Source | 5,525,000Source | — |
| Earnings Per Share, BasicUSD per share | — | — | — | — | — | 1.53Source | -0.48Source | 0.14Source | 0.94Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | — | 1.5Source | -0.48Source | 0.14Source | 0.94Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | — | — | 41,402,997Source | 40,828,380Source | 40,315,068Source | 38,997,649Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | — | — | — | 42,418,644Source | 40,828,380Source | 40,566,901Source | 38,997,649Source |
| Interest Expense (non-operating)USD | — | — | — | — | — | — | 853,000Source | — | — |
| Additional Financial Items | |||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | 3,573,000Source | — | — | 100,000Source |
| Debt Securities, Gain (Loss)USD | — | — | — | — | — | — | — | — | 43,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | 1,637,000Source | -7,784,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 383,000Source | 114,000Source | -252,000Source | 174,000Source | 2,172,000Source | 1,550,000Source |
| General and Administrative ExpenseUSD | — | 1,297,000Source | 1,664,000Source | 1,739,000Source | 727,000Source | 8,720,000Source | 6,457,000Source | 8,425,000Source | — |
| Gross ProfitUSD | — | — | — | — | — | 13,000Source | — | — | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | — | — | — | — | -37,664,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | -8,853,000Source | 11,604,000Source | 11,164,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 100,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | 2,037,000Source | — |
| Interest Expense, DebtUSD | — | — | — | — | — | — | 2,587,000Source | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | — | — | — | — | 4,128,000Source | 8,016,000Source | 3,473,000Source |
| Interest Income, OtherUSD | — | — | — | — | — | 2,373,000Source | — | 10,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -7,890,000Source | -5,570,000Source | 63,242,000Source | — | — | -36,561,000Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | 89,454,000Source | -2,286,000Source | 22,894,000Source | — |
| Other ExpensesUSD | — | — | — | — | — | 238,000Source | 265,000Source | 236,000Source | 264,000Source |
| Other General ExpenseUSD | — | — | — | — | — | — | — | — | 1,040,000Source |
| Other IncomeUSD | — | — | — | — | — | 958,000Source | 67,000Source | 143,000Source | 100,000Source |
| Research and Development ExpenseUSD | — | 5,502,000Source | 3,869,000Source | 6,410,000Source | 5,774,000Source | 6,381,000Source | 6,324,000Source | 8,971,000Source | 27,639,000Source |
| Operating Expenses | — | — | — | —Source | —Source | — | — | — | — |
| Selling and Marketing Expense | — | — | — | —Source | — | — | — | — | — |
Filing attachments
ea031155701ex4-1.htm · 10-Q · 2026-11-12
Exhibit 4.1 THE SECURITIES REFERENCED HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. ANY TRANSFEREE OF THIS NOTE SHOULD…
Read attachment ↗ea031155701ex4-2.htm · 10-Q · 2026-11-12
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…
Read attachment ↗ea031155701ex4-3.htm · 10-Q · 2026-11-12
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSA…
Read attachment ↗ea029507501ex99-1.htm · SCHEDULE 13D/A · 2026-06-17
Exhibit 99.1 ANNEX A RECENT TRANSACTIONS BY THE REPORTING PERSONS IN THE SECURITIES OF Nano Dimension Ltd. Entity Date of Transaction Description Shares Acquired Shares Price of Transaction Disposed Per Share ─────────────────────────────────────────────────────────────────────…
Read attachment ↗ea027438401ex99-1_nano.htm · SCHEDULE 13D · 2026-01-29
Exhibit 99.1 JOINT FILING AGREEMENT January 29, 2026 In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value NIS 5.00 per share, of Nano Dimension Ltd., and that this Joint Filing Agreement be included as an Exhibit to such joint filing. Each of the undersigned acknowled…
Read attachment ↗ea027288901ex4-1_oramed.htm · 8-K · 2026-01-14
Exhibit 4.1 EXHIBIT A NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR …
Read attachment ↗